Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 41Terminated 10Active not recruiting 7Unknown 6Withdrawn 4Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Other 1

Conditions

Nasopharyngeal Carcinoma 20Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 7Prostatic Neoplasms 5Carcinoma 4Rectal Neoplasms 3Nasopharyngeal Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Stomatitis 2Pancreatic Adenocarcinoma 2Neoplasm Metastasis 2Meningeal Carcinomatosis 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tumor Virus Infections 1Thyroid Carcinoma, Anaplastic 1Stomatognathic Diseases 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sarcoma 1Recurrence 1

Interventions

pembrolizumab 26Cisplatin 17Radiotherapy 13Carboplatin 13Blood Specimen Collection 10Cetuximab 9Docetaxel 8Paclitaxel 7Fluorouracil 7Drug Therapy 7toripalimab 5tislelizumab 4nimotuzumab 4atezolizumab 4Surveys and Questionnaires 4Radiation 4Chemoradiotherapy 4Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Biopsy 3130-nm albumin-bound paclitaxel 3fludarabine 2cemiplimab 2avelumab 2X-Rays 2Tocopherols 2Tiragolumab 2Therapeutics 2Tablets 2Standard of Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Head and Neck Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT06137274 2026-04-01

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT05388773 2025-06-19

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

University of Pittsburgh

Phase 2 Recruiting
150 enrolled
Head & Neck

Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Stomatognathic Diseases, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Papilloma, Pharyngeal Diseases, Pharyngeal Neoplasms, Tumor Virus Infections, Papillomavirus Infections

NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡